Logo image

Spinal muscular atrophy treatment with disease-modifying therapy

Spinal muscular atrophy treatment with disease-modifying therapy
Media Files


Type of care




About the offer

The main goal of disease-modifying therapy for patients with spinal muscular atrophy is to slow the development of the symptoms. In some rare cases, the progression of the disease might even be stopped for some time, which is certainly better compared to the entire absence of treatment. Before starting any treatment, medical practitioners try to obtain as much information about the course of the disease and the patient’s current condition. As a result, the patient should undergo numerous medical diagnostic procedures and lab tests. Currently, the FDA approves two main medications for a disease-modifying therapy for spinal muscular atrophy: Risdiplam (Evrysdi) and Nusinersen (Spinraza). Both drugs can help to increase the production of SMN protein, which is necessary for the normal functioning of motor neurons (nerve cells responsible for controlling movement). Also, both medications can be used for adults and childer over two months old. Spinraza is a liquid drug that is most often delivered via injections in the spinal canal. As a result, medication mixes up with cerebrospinal fluid and causes a complex effect on the whole organism. Evrysdi is usually prescribed in an oral-administer form, which is more comfortable, but might be more costly.

What’s included

Medical service

  • clinical history-taking
  • medical records review
  • physical examination
  • consultation with a neurologist
  • consultation with a genetic specialist
Laboratory tests
  • complete blood count (CBC)
  • biochemical analysis of blood (kidney and liver function tests)
  • inflammation blood tests
  • DNA test for SMN gene mutation (on the indication, price is not included)
  • neurological examination
  • electromyography
  • nerve conduction study
  • muscle biopsy (on the indication, price is not included)
  • histopathological specimen examination (on the indication, price is not included)
  • pre-procedure patient preparation
  • disease-modifying therapy for SMA to stimulate the production of SMN proteinSpinraza/Evrysdi
  • post-procedure care
  • symptomatic treatment
  • cost of essential medicines
  • cost of essential materials
  • nursing service
  • discharge medical records
  • further recommendations


AiroMedical support
Payment protection
Patient advocacy
Price match


Customize this offer

If you're not seeing exactly what you need here, send your custom request. You can discuss the content, specifics, price & timeline to create a personalized plan.


How long does the offer take?

The offer is designed for 7 days.

Does the offer require you to stay in the clinic overnight?

Where can I see the media files?

What are the age restrictions?

The offer is eligible for both adults and kids.

Can I customize the content of the offer?

Yes, the components of the deal can be changed. Get in touch with a vendor to create a personalized proposal.

Individual cost estimate. Non-binding 100% free assessment.

Similar deals